The trademark application RELISTOR was filed by Salix Pharmaceuticals, Inc., a U.S. corporation (the "Applicant"). The application was published for oppositions on October 18, 2022, and it was registered by office on January 25, 2023 without any oppositions.
The application was filed in English (German was selected as the second language).
The application claimed as seniority of the French Republic trademark 3443402 and filed on July 27, 2006 which was accepted by the office.